Drug Type Chemical drugs |
Synonyms SNH-119014 |
Target |
Action stimulants |
Mechanism Pyruvate kinases stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia, Sickle Cell | Phase 2 | China | 23 Apr 2026 | |
| Beta-Thalassemia | Phase 2 | China | 23 Apr 2026 |





